An overview of conceptual frameworks, analytical approaches of the digital therapeutics market is the main objective of the report, which further consists of the market opportunity and insights of the data involved in the making of the respective market. The digital therapeutics market is expected to grow at a significant rate in the near future.
The global digital therapeutics market in 2020 is estimated for more than US$ 3.7 Bn and expected to reach a value of US$ 22.9 Bn by 2028 with a significant CAGR of 25.8%.
Digital Therapeutics Market Definition
The digital Therapeutics market includes a couple of segments such as application and end-use. The application segment further divided into six other categories such as diabetes, obesity, CVD, CNS, respiratory, and others. The end-user segment is further divided into patients, caregivers, employers, payers, and pharmaceutical companies.
Furthermore, the study includes market estimation, market forecast, and market information for six geographical regions around the globe. In 2016, in the U.S. diabetes is the seventh major cause of death, which affects around 10% of the U.S. population that is around 30.0 million and around 95% of diabetic patients have type 2 diabetes that is significantly associated with behavioral factors such as heavy calorie intake and less physical activity.
Digital Therapeutics Market Dynamics
In the healthcare system diabetes costs around US$ 245 Bn annually of which around US$ 176 Bn is included under direct medical costs. Medical management under digital therapeutics for the patients includes a change in diet recommendations, physical activities and smoking cessation, oral anti-diabetic agents, insulin therapy, and complication preventions that are linked with diabetes, such as cardiovascular risk factor management.
Change in demographics is one of the important aspects for the growth in the health care industry as most of the countries are experiencing a high percentage of transformation in the young population into the aged population. According to World Bank Data, in 2013, the total healthcare spending globally was $7.2 trillion, which accounts for around 11.0% of global GDP and expected to grow at more than 5.0% annually to 2018. The result of global healthcare spending leads to an increase in life expectancy that leads to an aging population.
Furthermore, the UN forecasts that the global share of the population over the age of 60 is expected to increase from 11.7% in 2013 to 21.1% in 2050, with rise in chronic ailments, which in turn is expected to favor the market for digital therapeutics market in the near future.
Digital Therapeutics Market Key Players
The global digital therapeutics market is mainly dominated by Omada Health, NeuroTrack Technologies, Inc., ZappRx, MEDIMETRICS, Arthro Therapeutics, BiogeniQ, Oviva AG, Healark, Pathology Diagnostics Ltd., between MD, LLC.
Digital Therapeutics Market Segmentation
The digital therapeutics market is segmented on the basis of application, end-use, and region.
By Application
• Preventive Applications
o Prediabetes
o Obesity
o Nutrition
o Lifestyle Management
o Others
• Treatment Applications
o Diabetes
o CNS Disorders
o Chronic Respiratory Disorders
o Musculoskeletal Disorders
o Cardiovascular Diseases
o Smoking Cessation
o Medication Adherence
o Gastrointestinal Disorders
o Substance Use & Addiction Management
o Rehabilitation & Patient Care
o Others
By end-use global digital therapeutics market is segmented into Patients, Caregivers, Employers, Payers, and Pharmaceutical Companies.
The rise in digital education and ease in data quantification in the life science and biotechnology industry is the first and foremost factor driving demand for digital therapeutics in the global market. Increasing research and development activities in therapeutic industries would further increase the demand for more use of digital therapeutics. Technological advancements in various therapies is one of the main factor driving the growth of this market.
Digital Therapeutics Market Regional Overview and Analysis
On the basis of region, the global digital therapeutics market is segmented into six regions namely North America, Latin America, Asia Pacific, Europe, Middle East, and Africa. North America digital therapeutics market is expected to be the most dominating market throughout the forecast period due to an increasing number of biotechnology companies and research institutes in the U.S. Whereas, Europe will maintain its second-largest position with Germany and U.K being the most attractive markets within the region.
MMC Overview on Digital Therapeutics Market Report
The non-identical approach of Meridian Market Consultants stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give a better opportunity for the customers to put their effort.
A research report on the Digital Therapeutics market by Meridian Market Consultants is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that support the market and the factors that are acting as impedance for the growth of the market.
Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market. The report is titled ‘Digital Therapeutics Market: Opportunity Analysis and Future Assessment 2020-2028’.
Factors that are benchmarked while estimating the market
Various factors that are benchmarked while estimating the market growth includes (but not restricted to):
• New product designs and launches
• Current product compliance
• Reimbursement
• Concerns for use of Digital Therapeutics
• Advantages of Digital Therapeutics over other modalities
Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to take informed decision.
A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s products sales, previous growth rates and market expansion plans are considered to generate market share in the global market.
1. Report Overview/Executive Summary
1.1. Global Digital Therapeutics Market Report Overview
1.2. Introduction
1.3. Report Description
1.4. Methodology
2. Introduction to the Global Digital Therapeutics Market
2.1. Introduction
2.1.1. Market Definition
2.1.2. Market Taxonomy
2.2. Global Digital Therapeutics Market Snapshot
2.3. Global Digital Therapeutics Market Size and Forecast, 2018–2028
2.3.1. Introduction
2.3.2. Market Value Forecast and Y-0-Y Growth Rate (2018–2028)
2.4. Global Digital Therapeutics Market Dynamics
2.4.1. Drivers
2.4.2. Restraints
2.4.3. Opportunity
2.4.4. Trends
2.5. Key Regulations
2.6. Pest Analysis
3. Global Digital Therapeutics Market, By Application
3.1. Introduction
3.1.1. AGR% Comparison, By Application
3.1.2. BPS Analysis, By Application
3.1.3. Market Revenue Forecast, By Application
3.2. Diabetes
3.2.1. Market Revenue Forecast US$, 2018–2028
3.3. Obesity
3.3.1. Market Revenue Forecast US$, 2018–2028
3.4. Cardiovascular Disease
3.4.1. Market Revenue Forecast US$, 2018–2028
3.5. Central Nervous System Disorder
3.5.1. Market Revenue Forecast US$, 2018–2028
3.6. Respiratory
3.6.1. Market Revenue Forecast US$, 2018–2028
3.7. Other
3.7.1. Market Revenue Forecast US$, 2018–2028
3.8. Global Digital Therapeutics Market Attractiveness Index, By Application
4. Global Digital Therapeutics Market, By End Use
4.1. Introduction
4.1.1. AGR% Comparison, By End Use
4.1.2. BPS Analysis, By End Use
4.1.3. Market Revenue Forecast, By End Use
4.2. Patients
4.2.1. Market Revenue Forecast US$, 2018–2028
4.3. Caregivers
4.3.1. Market Revenue Forecast US$, 2018–2028
4.4. Emloyers
4.4.1. Market Revenue Forecast US$, 2018–2028
4.5. Players
4.5.1. Market Revenue Forecast US$, 2018–2028
4.6. Pharmaceutical Companies
4.6.1. Market Revenue Forecast US$, 2018–2028
4.7. Global Digital Therapeutics Market Attractiveness Index, By End Use
5. Global Digital Therapeutics Market, By Region
5.1. Introduction
5.1.1. AGR% Comparison, By Region
5.1.2. BPS Analysis, By Region
5.1.3. Market Revenue Forecast, By Region
5.2. North America
5.2.1. Market Revenue Forecast US$, 2018–2028
5.3. Latin America
5.3.1. Market Revenue Forecast US$, 2018–2028
5.4. Europe
5.4.1. Market Revenue Forecast US$, 2018–2028
5.5. Asia Pacific
5.5.1. Market Revenue Forecast US$, 2018–2028
5.6. Middle East and Africa
5.6.1. Market Revenue Forecast US$, 2018–2028
5.7. Global Digital Therapeutics Market Attractiveness Index, By Region
6. North America Digital Therapeutics MarketAnalysis and Forecast, 2018–2028
6.1. Introduction
6.1.1. AGR% Comparison, By Country
6.1.2. BPS Analysis, By Country
6.1.3. Market Revenue Forecast, By Country
6.2. U.S. Digital Therapeutics Market
6.2.1. Market Revenue Forecast US$, 2018–2028
6.3. Canada Digital Therapeutics Market
6.3.1. Market Revenue Forecast US$, 2018–2028
6.4. North America Digital Therapeutics Market, By Application
6.4.1. Diabetes
6.4.1.1. Market Revenue Forecast US$, 2018–2028
6.4.2. Obesity
6.4.2.1. Market Revenue Forecast US$, 2018–2028
6.4.3. Cardiovascular Disease
6.4.3.1. Market Revenue Forecast US$, 2018–2028
6.4.4. Central Nervous System Disorder
6.4.4.1. Market Revenue Forecast US$, 2018–2028
6.4.5. Respiratory
6.4.5.1. Market Revenue Forecast US$, 2018–2028
6.4.6. Other
6.4.6.1. Market Revenue Forecast US$, 2018–2028
6.5. North America Digital Therapeutics Market, By End Use
6.5.1. Patients
6.5.1.1. Market Revenue Forecast US$, 2018–2028
6.5.2. Caregivers
6.5.2.1. Market Revenue Forecast US$, 2018–2028
6.5.3. Emloyers
6.5.3.1. Market Revenue Forecast US$, 2018–2028
6.5.4. Players
6.5.4.1. Market Revenue Forecast US$, 2018–2028
6.5.5. Pharmaceutical Companies
6.5.5.1.1. Market Revenue Forecast US$, 2018–2028
6.6. North America Digital Therapeutics Market Attractiveness Index
6.6.1. By Country
6.6.2. By Application
6.6.3. By End Use
7. Latin America Digital Therapeutics Market Analysis and Forecast, 2018–2028
7.1. Introduction
7.1.1. AGR% Comparison, By Country
7.1.2. BPS Analysis, By Country
7.1.3. Market Revenue Forecast, By Country
7.2. Brazil Digital Therapeutics Market
7.2.1. Market Revenue Forecast US$, 2018–2028
7.3. Mexico Digital Therapeutics Market
7.3.1. Market Revenue Forecast US$, 2018–2028
7.4. Rest of Latin America Digital Therapeutics Market
7.4.1. Market Revenue Forecast US$, 2018–2028
7.5. Latin America Digital Therapeutics Market, By Application
7.5.1. Diabetes
7.5.1.1. Market Revenue Forecast US$, 2018–2028
7.5.2. Obesity
7.5.2.1. Market Revenue Forecast US$, 2018–2028
7.5.3. Cardiovascular Disease
7.5.3.1. Market Revenue Forecast US$, 2018–2028
7.5.4. Central Nervous System Disorder
7.5.4.1. Market Revenue Forecast US$, 2018–2028
7.5.5. Respiratory
7.5.5.1. Market Revenue Forecast US$, 2018–2028
7.5.6. Other
7.5.6.1. Market Revenue Forecast US$, 2018–2028
7.6. Latin America Digital Therapeutics Market, By End Use
7.6.1. Patients
7.6.1.1. Market Revenue Forecast US$, 2018–2028
7.6.2. Caregivers
7.6.2.1. Market Revenue Forecast US$, 2018–2028
7.6.3. Emloyers
7.6.3.1. Market Revenue Forecast US$, 2018–2028
7.6.4. Players
7.6.4.1. Market Revenue Forecast US$, 2018–2028
7.6.5. Pharmaceutical Companies
7.6.5.1. Market Revenue Forecast US$, 2018–2028
7.7. Latin America Digital Therapeutics Market Attractiveness Index
7.7.1. By Country
7.7.2. By Application
7.7.3. By End Use
8. Europe Digital Therapeutics MarketAnalysis and Forecast, 2018–2028
8.1. Introduction
8.1.1. AGR% Comparison, By Country
8.1.2. BPS Analysis, By Country
8.1.3. Market Revenue Forecast, By Country
8.2. U.K. Digital Therapeutics Market
8.2.1. Market Revenue Forecast US$, 2018–2028
8.3. France Digital Therapeutics Market
8.3.1. Market Revenue Forecast US$, 2018–2028
8.4. Germany Digital Therapeutics Market
8.4.1. Market Revenue Forecast US$, 2018–2028
8.5. Italy Digital Therapeutics Market
8.5.1. Market Revenue Forecast US$, 2018–2028
8.6. Spain Digital Therapeutics Market
8.6.1. Market Revenue Forecast US$, 2018–2028
8.7. Russia Digital Therapeutics Market
8.7.1. Market Revenue Forecast US$, 2018–2028
8.8. Rest of Europe Digital Therapeutics Market
8.8.1. Market Revenue Forecast US$, 2018–2028
8.9. Europe Digital Therapeutics Market, By Application
8.9.1. Diabetes
8.9.1.1. Market Revenue Forecast US$, 2018–2028
8.9.2. Obesity
8.9.2.1. Market Revenue Forecast US$, 2018–2028
8.9.3. Cardiovascular Disease
8.9.3.1. Market Revenue Forecast US$, 2018–2028
8.9.4. Central Nervous System Disorder
8.9.4.1. Market Revenue Forecast US$, 2018–2028
8.9.5. Respiratory
8.9.5.1. Market Revenue Forecast US$, 2018–2028
8.9.6. Other
8.9.6.1. Market Revenue Forecast US$, 2018–2028
8.10. Europe Digital Therapeutics Market, By End Use
8.10.1. Patients
8.10.1.1. Market Revenue Forecast US$, 2018–2028
8.10.2. Caregivers
8.10.2.1. Market Revenue Forecast US$, 2018–2028
8.10.3. Emloyers
8.10.3.1. Market Revenue Forecast US$, 2018–2028
8.10.4. Players
8.10.4.1. Market Revenue Forecast US$, 2018–2028
8.10.5. Pharmaceutical Companies
8.10.5.1. Market Revenue Forecast US$, 2018–2028
8.11. Europe Digital Therapeutics Market Attractiveness Index
8.11.1. By Country
8.11.2. By Application
8.11.3. By End Use
9. Asia Pacific Digital Therapeutics Market Analysis and Forecast, 2018–2028
9.1. Introduction
9.1.1. AGR% Comparison, By Country
9.1.2. BPS Analysis, By Country
9.1.3. Market Revenue Forecast, By Country
9.2. China Digital Therapeutics Market
9.2.1. Market Revenue Forecast US$, 2018–2028
9.3. India Digital Therapeutics Market
9.3.1. Market Revenue Forecast US$, 2018–2028
9.4. Japan Digital Therapeutics Market
9.4.1. Market Revenue Forecast US$, 2018–2028
9.5. Australia and New Zealand Digital Therapeutics Market
9.5.1. Market Revenue Forecast US$, 2018–2028
9.6. ASEAN Digital Therapeutics Market
9.6.1. Market Revenue Forecast US$, 2018–2028
9.7. Rest of Asia Pacific Digital Therapeutics Market
9.7.1. Market Revenue Forecast US$, 2018–2028
9.8. Asia Pacific Digital Therapeutics Market, By Application
9.8.1. Diabetes
9.8.1.1. Market Revenue Forecast US$, 2018–2028
9.8.2. Obesity
9.8.2.1. Market Revenue Forecast US$, 2018–2028
9.8.3. Cardiovascular Disease
9.8.3.1. Market Revenue Forecast US$, 2018–2028
9.8.4. Central Nervous System Disorder
9.8.4.1. Market Revenue Forecast US$, 2018–2028
9.8.5. Respiratory
9.8.5.1. Market Revenue Forecast US$, 2018–2028
9.8.6. Other
9.8.6.1. Market Revenue Forecast US$, 2018–2028
9.9. Asia Pacific Digital Therapeutics Market, By End Use
9.9.1. Patients
9.9.1.1. Market Revenue Forecast US$, 2018–2028
9.9.2. Caregivers
9.9.2.1. Market Revenue Forecast US$, 2018–2028
9.9.3. Emloyers
9.9.3.1. Market Revenue Forecast US$, 2018–2028
9.9.4. Players
9.9.4.1. Market Revenue Forecast US$, 2018–2028
9.9.5. Pharmaceutical Companies
9.9.5.1. Market Revenue Forecast US$, 2018–2028
9.10. Asia Pacific Digital Therapeutics Market Attractiveness Index
9.10.1. By Country
9.10.2. By Application
9.10.3. By End Use
10. Middle East and Africa Digital Therapeutics Market, By Region
10.1. Introduction
10.1.1. AGR% Comparison, By Country
10.1.2. BPS Analysis, By Country
10.1.3. Market Revenue Forecast, By Country
10.2. GCC Countries Digital Therapeutics Market
10.2.1. Market Revenue Forecast US$, 2018–2028
10.3. South Africa Digital Therapeutics Market
10.3.1. Market Revenue Forecast US$, 2018–2028
10.4. North Africa Digital Therapeutics Market
10.4.1. Market Revenue Forecast US$, 2018–2028
10.5. Middle East and Africa Digital Therapeutics Market, By Application
10.5.1. Diabetes
10.5.1.1. Market Revenue Forecast US$, 2018–2028
10.5.2. Obesity
10.5.2.1. Market Revenue Forecast US$, 2018–2028
10.5.3. Cardiovascular Disease
10.5.3.1. Market Revenue Forecast US$, 2018–2028
10.5.4. Central Nervous System Disorder
10.5.4.1. Market Revenue Forecast US$, 2018–2028
10.5.5. Respiratory
10.5.5.1. Market Revenue Forecast US$, 2018–2028
10.5.6. Other
10.5.6.1. Market Revenue Forecast US$, 2018–2028
10.6. Middle East and Africa Digital Therapeutics Market, By End Use
10.6.1. Patients
10.6.1.1. Market Revenue Forecast US$, 2018–2028
10.6.2. Caregivers
10.6.2.1. Market Revenue Forecast US$, 2018–2028
10.6.3. Emloyers
10.6.3.1. Market Revenue Forecast US$, 2018–2028
10.6.4. Players
10.6.4.1. Market Revenue Forecast US$, 2018–2028
10.6.5. Pharmaceutical Companies
10.6.5.1. Market Revenue Forecast US$, 2018–2028
10.7. Middle East and Africa Digital Therapeutics Market Attractiveness Index
10.7.1. By Country/Region
10.7.2. By Application
10.7.3. By End Use
11. Competitive Landscape
11.1. Company Profiles
11.1.1. Apria Healthcare Group
11.1.1.1. Company Overview
11.1.1.2. Financial Overview
11.1.1.3. Product Portfolio
11.1.1.4. Key Developments
11.1.1.5. Business Strategies
11.1.2. Omada Health
11.1.3. Canary Health
11.1.4. Noom Health
11.1.5. Livongo Health
11.1.6. WellDoc Inc.
11.1.7. Propeller Health
11.1.8. Evolent Health
11.1.9. Doximity
11.1.10. Perfint Healthcare
11.1.11. Proteus Digital Health
11.1.12. Nanobiosym
11.1.13. Zest Health
12. Conclusion
13. Acronyms
Frequently Asked Questions
What is the projected market size & Compound Annual Growth Rate (CAGR) of the market?
The global Digital Therapeutics Market in 2020 is estimated for more than US$ 3.7 Bn and expected to reach a value of US$ 22.9 Bn by 2028 with a significant CAGR of 25.8%.
What are the key factors driving the growth of market?
Technological advancement, change in demographics, and increasing geriatric population are some of the major factors which are expected to drive the growth of the market
What segments are covered in market report?
The digital therapeutics market is segmented on the basis of application, end-use, and region
What are the key participating players in the market?
The global digital therapeutics market is mainly dominated by Omada Health, NeuroTrack Technologies, Inc., ZappRx, MEDIMETRICS, Arthro Therapeutics, BiogeniQ, Oviva AG, Healark, Pathology Diagnostics Ltd., between MD, LLC.
